Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1.06 | 46.11 |
| PEG Ratio (TTM) | 0.01 | -15.88 |
| P/S Ratio (TTM) | 0.00 | 3.84 |
| P/B Ratio (TTM) | -0.06 | 5.97 |
| P/FCF Ratio (TTM) | -0.32 | 11.45 |
| Price to 5YR AVG Earnings Ratio | -1.00 | 34.06 |
| Price to 5YR AVG FCF Ratio | -0.52 | 53.52 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.96% | 12.60% |
| ROE (TTM) | -5.85% | 16.11% |
| Net Profit Margin (TTM) | 0.42% | 8.53% |
| ROIC 5YR AVG | 9.21% | 23.05% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -176.31% | -52.48% | -21.08% |
| Revenue | -5.61% | -2.52% | 1.66% |
| Net Income | -173.52% | -49.69% | -26.61% |
| Cash Flow | -57.91% | 95.89% | 278.95% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.27 | 1.27 |
| Quick Ratio (TTM) | 1.27 | 1.26 |
| D/E Ratio (TTM) | -3.47 | 10.16 |
| Interest Coverage (TTM) | 1.21 | 23.15 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 0.18 | 12.21 |
| LTL to 5YR AVG FCF | -14.07 | 1.00 |
| Shares Outstanding Growth 5YR AVG | 9.75% | -1.02% |